Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Valneva SE - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
VALN
Nasdaq
2830
valneva.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Valneva SE
MHRA revokes approval for Valneva’s Ixchiq due to safety frailties
- Oct 21st, 2026 4:08 am
Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences
- Oct 14th, 2026 9:45 am
Valneva Shares Fall as UK Withdraws Approval for Ixchiq Chikungunya Vaccine
- Oct 8th, 2026 4:09 am
VALN Stock Plunges 7% After-Hours As UK Revokes Valneva’s IXCHIQ Authorization In Latest Market Setback
- Oct 7th, 2026 3:09 pm
Valneva ADRs fall as UK revokes IXCHIQ marketing authorization
- Oct 7th, 2026 2:39 pm
Valneva Provides Update on IXCHIQ® in the United Kingdom
- Oct 7th, 2026 2:00 pm
Declaration of shares and voting rights - Status as of September 30, 2026
- Oct 5th, 2026 10:00 am
Could a New Vaccine Formula XFG Give Pfizer (PFE) and BioNTech (BNTX) a Post-Pandemic Revenue Boost?
- Sep 24th, 2026 2:27 pm
Pfizer (PFE), Valneva (VALN) Lyme Vaccine Moves to EMA Review Despite Phase 3 Caveat
- Sep 15th, 2026 10:21 am
Vaccines Global Market Intelligence Report 2026-2035 Featuring Bio Farma, Emergent BioSolutions, GC Pharma, GlaxoSmithKline, Janssen, Merck, Novavax, Moderna, Pfizer, Sanofi Pasteur, and Valneva
- Sep 7th, 2026 5:02 am
Declaration of shares and voting rights - Status as of August 31, 2026
- Sep 4th, 2026 10:00 am
The Bull Case For Pfizer (PFE) Could Change Following New COVID And Lyme Vaccine Milestones - Learn Why
- Aug 27th, 2026 11:07 pm
Valneva (VALN) Q2 2026 Earnings Call Transcript
- Aug 20th, 2026 1:44 pm
Pfizer (PFE) Gets EMA Lyme Vaccine Filing Validation As ADC Patent Clout Grows
- Aug 18th, 2026 11:13 am
Pfizer (PFE) Stock Looks Reasonable On Returns But Stretched On Earnings
- Aug 15th, 2026 12:11 am
Sector Update: Healthcare Stocks Decline Late Afternoon
- Aug 14th, 2026 1:51 pm
Stock Market Midday, Aug. 14: Stocks Wobble on Falling Consumer Confidence, Reddit Jumps 14%
- Aug 14th, 2026 10:35 am
Why Did VALN Stock Surge 24% Today?
- Aug 14th, 2026 9:54 am
Capricor shares spike on CEO comments; Cytokinetics sues Bristol Myers
- Aug 14th, 2026 3:28 am
Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
- Aug 13th, 2026 11:00 pm
Scroll